Epitalon vs Vesilute
Well Studied vs Moderate Research
compatible Often combined in comprehensive anti-aging bioregulator protocols.
Molecular Data
Epitalon Vesilute
Weight 390.35 Da 262 Da
Half-life Not established (short peptide) Not established
Chain 4 amino acids 2 amino acids
Type Tetrapeptide Dipeptide bioregulator
Key Benefits
Epitalon
01 Telomere extension and cellular replicative lifespan extension
02 Enhanced melatonin production
03 Improved immune function
04 Potential lifespan extension (25-33% in animal studies)
05 Systemic anti-aging through cellular rejuvenation
06 Short cycle duration with long-lasting effects
Vesilute
01 Supports bladder and urinary tract function
02 May improve prostate health in men
03 Regulates smooth muscle function
04 Enhances pelvic tissue blood flow
05 Supports cellular regeneration
06 Part of comprehensive Khavinson bioregulator protocols
07 Well-tolerated in research
08 Oral bioavailability as small dipeptide
Dosing Protocols
Epitalon
100-500mcg per injection / Once daily for 10-20 consecutive days
Standard anti-aging 200-500mcg 1x daily for 10-20 days
Conservative start 100mcg 1x daily for 10-20 days
Russian clinical equivalent 300mcg 1x daily for 10-20 days
Ultra-low dose 50mcg 1x daily for 10-20 days
Vesilute
10-20 mg per day / Daily for 10-20 consecutive days (Khavinson bioregulator cycle)
Standard protocol 10-20 mg Daily for 10-20 days
Maintenance 20 mg 2-3 cycles yearly
Side Effects
Epitalon
Generally well-tolerated with minimal side effects
Mild injection site reactions
Vivid dreams (melatonin-related)
Possible mild digestive upset (oral route)
Vesilute
Generally well-tolerated
Injection site reactions (mild, if injectable)
Minimal reported side effects
Contraindications
Active malignancy (telomerase activation concern)
Chronic sinusitis (nasal route)
Known peptide allergies
Pregnancy or breastfeeding
Known hypersensitivity to peptide components
Active urinary tract infection (treat first)
Pregnancy or breastfeeding
Prostate cancer (consult physician)
Research Evidence
Epitalon Vesilute
Status Well Studied Moderate Research
References 6 studies 3 studies
FDA Approved No No
This comparison is for educational and research purposes only. Consult a healthcare professional before use.